A Look at the Breast Cancer Landscape: An Expert's Take on the Newly Approved Daiichi Sankyo Drug, ENHERTU, SGEN's tucatinib, & the Role of IO therapyTicker(s): D4S.F, SGEN
An oncologist who is familiar with ticatinib.
277Days Left to Join Project
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.